ERBB2 and breast cancer: The pioneering studies conducted with microarrays for gene expression profiling performed by Sørlie et al. and Perou et al. generated a molecular portrait for classifying breast cancers (BC) into four intrinsic subtypes with different clinical outcomes, i.e., luminal A and B, HER2-positive and basal-like tumors1,2.